Sébastien Morin
@sebmoringva.bsky.social
56 followers 120 following 36 posts
Senior Manager - Policy, Strategy and Market Access Medicines Patent Pool (Switzerland) [ Posting on #GlobalHealth in personal capacity. ] ⭐️ Health is a human right ⭐️
Posts Media Videos Starter Packs
Reposted by Sébastien Morin
dndi.org
Children are too often left out of clinical trials. In Nature, our Head of HIV Justine Odionyi calls for drug development on neglected diseases to include children from the start. Read the piece (EN/FR): @nature.com #BeatNTDs #GlobalHealth www.nature.com/articles/d44...
Drug development for neglected diseases must account for kids
Including children in trials, shaping regulation locally, could deliver safer, more effective therapies in Africa.
www.nature.com
Reposted by Sébastien Morin
medicinespatentpool.org
Voluntary #LicensingSavesLives by making medicines and health technologies affordable for low- and middle-income countries. 🌍

🤝 But we cannot achieve this great change without your help!

👉 medicinespatentpool.org/licensingsav...
sebmoringva.bsky.social
Very #proud of being part of the amazing @medicinespatentpool.org #team! Together, we make a positive difference for #GlobalHealth!
medicinespatentpool.org
Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign.

Thank you to all colleagues for your energy, we look forward to what lies ahead!
sebmoringva.bsky.social
Ensuring #equity in #access is how we can transform #innovation into positive #health outcomes. Have a look at the short film below and read the latest article from colleagues on "Expanding access to long-acting #HIV therapy in low-income and middle-income countries" 💙
lnkd.in/eTd3TMDM
#GlobalHealth
sebmoringva.bsky.social
An #timely & #symbolic #milestone for long-acting #HIV #prevention and #treatment ! A privilege to be at #IAS2025 to share positive news with #partners of community, civil society, academia, governments, international organizations, industry...
--
#GlobalHealth #AccessToMedicines #Equity #Solidarity
medicinespatentpool.org
The MPP and ViiV have expanded their agreement to now include cabotegravir long-acting for both #HIV prevention and treatment.
This is the first fully long-acting HIV treatment made available through a voluntary licence in low- and middle- income countries.

#IAS2025 #ViiV #Unitaid
Reposted by Sébastien Morin
unitaid.bsky.social
Unitaid applauds ViiV Healthcare and the @medicinespatentpool.org for advancing equitable access to HIV treatment. Strong partnerships like this help deliver life-changing innovations to the communities that need them most.

Learn more: medicinespatentpool.org/news-publica...
Reposted by Sébastien Morin
medicinespatentpool.org
“We don’t have to explain ourselves all over again.”

In Kigali, we visited HDI, led by Dr. Aflodis Kagaba, where sex workers, LGBTQ+ people & people who use drugs find stigma-free care, every day.

✍️ Read the full story: medicinespatentpool.org/story-post/b...
Reposted by Sébastien Morin
medicinespatentpool.org
🚨 We’re hiring!
⚖️ Associate Counsel
💉 Consultant: Feasibility & Concept Design Expert

👉 Check out our career page for more information: medicinespatentpool.org/who-we-are/c...

#GlobalHealth #AccessToMedicines #mRNA #Vaccines #Hiring
sebmoringva.bsky.social
I just found this old postcard from a few years back... It remains true and could have been printed yesterday... 😢
---
#ChildHealth #PaediatricHIV #BetterMeds4Kids
sebmoringva.bsky.social
The recently-launched #GAPf strategy for 2025-2030 will include a focus on developing and rolling out #BetterMeds4Kids to address the increasing threat of #dengue...
www.who.int/publications...
who.int
WHO @who.int · Jul 10
Dengue, Zika, chikungunya & yellow fever are on the rise, putting 5.6B+ people at risk.

Once limited to tropical & subtropical climates, Aedes mosquitoes are spreading to new regions, increasing the risk of outbreaks.

New WHO guidelines covering all four mosquito-borne diseases 🔗 bit.ly/3Tu6BnJ
Tania attends to a patient in the dengue ward at Mugda Hospital in Dhaka, Bangladesh, on 20 September 2023.
Reposted by Sébastien Morin
bhekisisa.org
How is HIV science around the world navigating US funding cuts? Follow us as we bring you exclusive coverage from the 13th IAS Conference on HIV science in Kigali, Rwanda. #IAS2025 #HIVScience
Reposted by Sébastien Morin
avac.org
AVAC @avac.org · Jul 4
USAID has officially closed. Congress passed the President's domestic policy agenda, robbing about 17 million Americans access to health care in favor of tax cuts for the rich. The US Supreme Court preserved preventative care, including PrEP.

Read all about it, and more: avac.org/blog/global-...
sebmoringva.bsky.social
Looking forward to reconnecting at #IAS2025 and achieving #health #impact!

@medicinespatentpool.org
@iasociety.bsky.social
sebmoringva.bsky.social
Pushing the boundary, expanding #access to #health products. Lots achieved, but much more remains!
Join our efforts to allow populations of low- and middle-income countries often most affected by diseases reap the benefits of modern #medical #science! This is what #equity looks like!
#GlobalHealth
medicinespatentpool.org
📘 MPP's 2024 annual report, Breaking New Ground, shows that we continued to bring positive change for millions of people in LMICs across the globe, 🌍 with a significant expansion in #treatment uptake, #economic savings and #health benefits.

👉 medicinespatentpool.org/news-publica...
sebmoringva.bsky.social
Congratulations to #Botswana for being "validated as the 1st high #HIV-burden country [...], and the 1st in #Africa, to reach @who.int’s Gold Tier status for eliminating vertical transmission of HIV as a public #health issue"! An AIDS-free generation is possible!

www.afro.who.int/countries/bo...
Botswana leads the way in eliminating mother-to-child transmission of HIV
In a historic global health milestone, Botswana has been validated as the first high HIV-burden country in the world, and the first in Africa, to reach the World Health Organization’s Gold Tier status...
www.afro.who.int
sebmoringva.bsky.social
Each year, RSV kills 50,000 #infants <6 months, mostly in #LMICs. @who.int recommends #prevention with an #antibody (2 products now approved by regulatory agencies) or a #vaccine. There is hope. Let's ensure infants benefit from life-saving #progress!
#BetterMeds4Kids #ChildHealth
WHO outlines recommendations to protect infants against RSV – respiratory syncytial virus
Today, WHO published its first-ever position paper on immunization products to protect infants against respiratory syncytial virus (RSV) – the leading cause of acute lower respiratory infections in ch...
www.who.int
sebmoringva.bsky.social
Because “ #health is always the first to suffer when #funding falls short ” -> #donate to @who.int and help protect everyone’s health!

donate.who.foundation
Donate to WHO’s Emergency Response
Global health is under threat. Act for Global Health Today.
donate.who.foundation
sebmoringva.bsky.social
Very interesting lessons from COVID and pragmatic approach linking #research and #development with #equitable #access outcomes in mind

wellcomeopenresearch.org/articles/9-374
wellcomeopenresearch.org
Reposted by Sébastien Morin
unitaid.bsky.social
Unitaid a financé les études nécessaires à la préqualification par @who.int du TLD, dans le cadre d’une licence du @medicinespatentpool.org.

Ce soutien a permis d’aligner le produit sur les normes mondiales et d’ouvrir la voie à son approvisionnement international.
Reposted by Sébastien Morin
unitaid.bsky.social
Unitaid funded the studies required for @who.int prequalification, working under a @medicinespatentpool.org license. This support ensured that TLD met global quality standards and could be supplied through international procurement channels.

🧵👇
Reposted by Sébastien Morin
medicinespatentpool.org
🌍 🤝 We just signed an MOU with #Vizuri Health Dynamics and @medicinespatentpool.org! This partnership will focus on understanding the African pharmaceutical sector, leveraging networks, and fostering product adoption. Exciting times ahead.

#AccessToMedicines #LocalProduction #HealthInnovation